Home » Ranbaxy Launches Evoxac AG
Ranbaxy Launches Evoxac AG
Ranbaxy has begun marketing an authorized generic of Daiichi Sankyo’s dry-mouth treatment Evoxac in the U.S. per an agreement with the Japanese drugmaker. A generic version of Evoxac (cevimeline HCl) was also brought to market by Apotex this quarter following a patent settlement with Daiichi.
Generic Line
Generic Line
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May